- About The Editors
- Acknowledgements
- Acute Efficacy of Antiarrhythmic Drugs in ARVCD
- Altered Expression and Distribution of Cell Cell Junction Proteins in Human Cardiomyopathies
- Animal Models
- Animal Models in Cardiomyopathies
- Antiarrhythmic Drug Therapy - 2
- Appropriate Therapies and Life Saving Interventions
- Arrhythmogenic Right Ventricular Cardiomyopathy Dysplesia
- Arvcd A Leading Cause of Sudden Death in Young Athletes
- ARVCD Linked to Mutations of TGFbeta 3 Gene
- Cardiomyocyte Dedifferentiation
- Cardiomyocyte Transdifferentiation
- Catheter Ablation
- Causative Role of Viruses
- Causes of Sudden Death in Young Athletes Italian vs US Experience
- Cell Death
- Strengths And Weaknesses Of The Task Force Criteria
- Clinical Diagnosis of ARVCD
- Clinical Manifestations - 2
- Clinical Profile of Athletes Dying Suddenly from ARVCD
- Clinical Series
- Comments
- Computed Tomography of ARVCD
- Conclusions - 2 3 4 5 6 7 8 9 10 11
- Contributing Role of Viruses
- Cytoskeleton
- Definition
- Depolarization Conduction Abnormalities
- Device Selection
- Disease Genes
- Dysplasia
- Echocardiographic Natural History of ARVCD
- Efficacy of ICDs in ARVCD
- Electrocardiographic Findings in the Arvcd Task Force Criteria
- Electrophysiologic Characteristics
- Electrophysiologic Study with Programmed Ventricular Stimulation
- Epsilon Waves
- Etiology and Pathogenesis of ARVCD
- General Characteristics
- Gross Pathology
- Heart Failure in ARVCD
- Histopathology - 2
- How to Perform Right Ventricular Angiography in ARVCD
- Human Studies
- I
- In Vivo Tissue Characterization by EMB
- Introduction - 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18
- Junctional Plakoglobin Mutant Murine Models
- List Of Contributors
- Long Term Efficacy of Antiarrhythmic Drugs in ARVCD
- Management of Heart Failure
- Management of Symptomatic Patients
- Mechanisms
- Mechanisms Regulating Expression of Cell Cell Junction Proteins in Response to Mechanical Load
- Methods
- Molecular Pathogenesis
- Mouse Models of Human Cardiomyopathies
- MR Imaging of ARVCD
- Mutation Screening
- Natural History Mode of Death and Risk Stratification
- Naxos Disease History
- Negative T Waves
- Novel Echocardiographic Tools to Assess ARVCD
- Overview of VT Ablation in the Literature
- Overview of VT Management
- Pathogenesis of ARVCD
- Pathogenesis Virus and Myocyte Death
- Pathological Findings Suggestive for Infective Inflammatory Disease
- Pathophysiology
- Plakophilin2 Mutant Murine Models
- Predictive Value of Electrophysiologic Study
- Predictors of ICD Therapy
- Preface
- Preparticipation Screening and Prevention of Sudden Death
- Prognosis
- QRS Duration and Morphology
- QT Dispersion
- Qualitative Echocardiographic Features of ARVCD
- Quantitative Analysis of Right Ventricular Wall Motion
- Quantitative Echocardiographic Features of ARVCD
- References - 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
- Repolarization Abnormalities
- Results
- Risk of Sudden Death from Arvcd During Physical Exercise
- Risk Stratification
- Risk Adapted Treatment Algorithms in ARVCD
- Ryanodine Receptor Mutant Murine Models
- Safety of ICD Implantation in ARVCD
- Selection of Cases
- Serial Electrocardiographic Evaluation in ARVCD
- Sports Eligibility
- Structural Abnormalities of the Right Ventricle in ARVCD
- Structural Investigation Echocardiography and Magnetic Resonance Imaging
- Table Of Contents
- Tachycardia induced Cardiomyopathy
- The Presence of Arrhythmias
- The Role of Right Ventricular Angiography in ARVCD
- Tissue Characterization of Walls
- Treatment Options
- Ventricular Arrhythmias
- Ventricular Cardiomyopathy Dysplasia Clarified
- Voltage Mapping Clinical Implications